Citation: | LI Yu, XIANG Ping, KONG Lingquan, HUANG Tao. Clinical diagnosis, treatment and analysis of 71 cases of chromophobe renal cell carcinoma in a single center[J]. Chinese Journal of General Practice, 2023, 21(9): 1453-1456. doi: 10.16766/j.cnki.issn.1674-4152.003144 |
[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
|
[2] |
GARJE R, ELHAG D, YASIN H A, et al. Comprehensive review of chromophobe renal cell carcinoma[J]. Crit Rev Oncol Hematol, 2021, 160: 103287. DOI: 10.1016/j.critrevonc.2021.103287.
|
[3] |
WARREN A Y, HARRISON D. WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies[J]. World J Urol, 2018, 36(12): 1913-1926. doi: 10.1007/s00345-018-2447-8
|
[4] |
THOENES W, STÖRKEL S, RUMPELT H J. Human chromophobe cell renal carcinoma[J]. Virchows Arch B Cell Pathol Incl Mol Pathol, 1985, 48(3): 207-217.
|
[5] |
王旭, 宋歌, 王宗平, 等. 早期富血供超小肾癌与肾乏脂肪血管平滑肌脂肪瘤的CT鉴别诊断[J]. 中华全科医学, 2020, 18(6): 989-993, 1017. doi: 10.16766/j.cnki.issn.1674-4152.001410
WANG X, SONG G, WANG Z P, et al. CT differential diagnosis of early ultra-small renal carcinoma with rich blood supply and adipose-deficient renal angiomyolipoma[J]. Chinese Journal of General Practice, 2020, 18(6): 989-993, 1017. doi: 10.16766/j.cnki.issn.1674-4152.001410
|
[6] |
于永梅, 王敏, 翟蕊, 等. CT对肾细胞癌亚型的诊断及鉴别诊断[J]. 实用放射学杂志, 2022, 38(10): 1659-1663. doi: 10.3969/j.issn.1002-1671.2022.10.023
YU Y M, WANG M, ZHAI R, et al. CT diagnosis and differential diagnosis of renal cell carcinoma subtypes[J]. Journal of Practical Radiology, 2022, 38(10): 1659-1663. doi: 10.3969/j.issn.1002-1671.2022.10.023
|
[7] |
REN W, XUE B, QU J, et al. Localized chromophobe renal cell carcinoma: preoperative imaging judgment and laparoscopic simple enucleation for treatment[J]. Int Braz J Uro, 2018(5): 922-932.
|
[8] |
MARKO J, CRAIG R, NGUYEN A, et al. Chromophobe renal cell carcinoma with radiologic-pathologic correlation[J]. Radiographics, 2021, 41(5): 1408-1419. doi: 10.1148/rg.2021200206
|
[9] |
张巍, 李真真, 陈洁, 等. 肾嗜酸细胞瘤的临床病理特征[J]. 中国组织化学与细胞化学杂志, 2022, 31(1): 52-57, 67. https://www.cnki.com.cn/Article/CJFDTOTAL-GGZZ202201007.htm
ZHANG W, LI Z Z, CHEN J, et al. Clinicopathological features of renal eosinophilic tumours[J]. Chinese Journal of Histochemistry and Cytochemistry, 2022, 31(1): 52-57, 67. https://www.cnki.com.cn/Article/CJFDTOTAL-GGZZ202201007.htm
|
[10] |
ALAGHEHBANDAN R, PRZYBYCIN C G, VERKARRE V, et al. Chromophobe renal cell carcinoma: novel molecular insights and clinicopathologic updates[J]. Asian J Urol, 2022, 9(1): 1-11. doi: 10.1016/j.ajur.2021.11.010
|
[11] |
白红松, 王栋, 温力, 等. 126例肾嫌色细胞癌的诊治分析[J]. 中国医学科学院学报, 2021, 43(2): 247-252. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYKX202102015.htm
BAI H S, WANG D, WEN L, et al. Diagnosis and treatment of 126 cases of chromophobe renal cell carcinoma[J]. Journal of Chinese Academy of Medical Sciences, 2021, 43(2): 247-252. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYKX202102015.htm
|
[12] |
YANG J, GONG C, ZHAO J, et al. Effects of BAP1, Ki-67 index, and Id-1 in patients with clear cell renal carcinoma and their correlation with clinical features and prognosis[J]. Transl Androl Urol, 2020, 9(5): 2242-2250. doi: 10.21037/tau-20-1258
|
[13] |
SONG J, YU Z, DONG B, et al. Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma[J]. World J Surg Oncol, 2021, 19(1): 156. doi: 10.1186/s12957-021-02268-5
|
[14] |
CASUSCELLI J, BECERRA M F, SEIER K, et al. Chromophobe renal cell carcinoma: results from a large single-institution series[J]. Clin Genitourin Cancer, 2019, 17(5): 373-379. e4. doi: 10.1016/j.clgc.2019.06.011
|
[15] |
GED Y, CHEN Y B, KNEZEVIC A, et al. Metastatic chromophobe renal cell carcinoma: presence or absence of sarcomatoid differentiation determines clinical course and treatment outcomes[J]. Clin Genitourin Cancer, 2019, 17(3): e678-e688. doi: 10.1016/j.clgc.2019.03.018
|
[16] |
NEVES J B, VANACLOCHA SAIZ L, ABU-GHANEM Y, et al. Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma[J]. World J Urol, 2021, 39(10): 3823-3831. doi: 10.1007/s00345-021-03683-9
|
[17] |
PECORARO A, PALUMBO C, KNIPPER S, et al. Synchronous metastasis rates in T1 renal cell carcinoma: a surveillance, epidemiology, and end results database-based study[J]. Eur Urol Focus, 2021, 7(4): 818-826. doi: 10.1016/j.euf.2020.02.011
|